China’s first AI model for rare diseases enters public testing
Matthew Brady
Patients can use a rare disease LLM developed by PUMCH and Institute of Automation, Chinese Academy of Sciences for consultations and appointments.
Independent intelligence on healthtech across Asia and the Middle East
Patients can use a rare disease LLM developed by PUMCH and Institute of Automation, Chinese Academy of Sciences for consultations and appointments.